Literature DB >> 28668263

Meta-analysis of Predictors of Early Severe Bleeding in Patients Who Underwent Transcatheter Aortic Valve Implantation.

Yinghao Sun1, Xianbao Liu1, Zexin Chen2, Jiaqi Fan1, Jubo Jiang1, Yuxin He1, Qifeng Zhu1, Po Hu1, Lihan Wang1, Qiyuan Xu1, Xiaoping Lin1, Jian'an Wang3.   

Abstract

Severe bleeding (SB) in patients who underwent transcatheter aortic valve implantation (TAVI) could be fatal. Although multiple independent predictors of bleeding post-TAVI have been identified, the definitions of bleeding and predictors vary across studies. This study aimed to provide summary effect estimates for predictors of SB within 30 days post-TAVI. A systematic review of studies that reported the incidence of bleeding post-TAVI with raw data for predictors of interest was performed. Data on characteristics of study, patient, and procedure were extracted. Crude risk ratios (RRs) and 95% confidence intervals were calculated using random-effect model. Fifteen predictors on 65,209 patients from 47 studies were analyzed. The median rate of SB was 11% across studies. Seven factors (3 patient related and 4 procedure related) were recognized as predictors of early SB post-TAVI. Age ≥90 years (RR 1.17; p = 0.008), female (RR 1.13; p = 0.01), and sheath diameter >19 Fr (RR 1.19; p = 0.04) were weak predictors. Chronic kidney disease (RR 1.94; p <0.001) and transapical (TA) (RR 1.82; p <0.001) were moderate predictors that were almost associated with twofold risk. Vascular complication (RR 2.97; p <0.001) and circulatory support (RR 3.39; p <0.001) were strong predictors that were nearly associated with threefold risk. In conclusion, age, gender, chronic kidney disease, TA, sheath diameter, vascular complication, and circulatory support were all predictors of early SB post-TAVI in this meta-analysis, which provided possible guidance for prevention and management of SB related to TAVI.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28668263     DOI: 10.1016/j.amjcard.2017.05.035

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

Review 1.  Antithrombotic Therapy Following Transcatheter Aortic Valve Replacement.

Authors:  Camille Granger; Paul Guedeney; Jean-Philippe Collet
Journal:  J Clin Med       Date:  2022-04-14       Impact factor: 4.964

2.  Mortality after transcatheter versus surgical aortic valve replacement: an updated meta-analysis of randomised trials.

Authors:  H Takagi; Y Hari; K Nakashima; T Kuno; T Ando
Journal:  Neth Heart J       Date:  2020-06       Impact factor: 2.380

Review 3.  Transcatheter aortic valve replacement over age 90: Risks vs benefits.

Authors:  Christos Galatas; Jonathan Afilalo
Journal:  Clin Cardiol       Date:  2019-12-16       Impact factor: 2.882

4.  Previously implanted mitral surgical prosthesis in patients undergoing transcatheter aortic valve implantation: Procedural outcome and morphologic assessment using multidetector computed tomography.

Authors:  Makoto Tanaka; Ryo Yanagisawa; Fumiaki Yashima; Takahide Arai; Masahiro Jinzaki; Hideyuki Shimizu; Keiichi Fukuda; Yusuke Watanabe; Toru Naganuma; Shinichi Shirai; Motoharu Araki; Norio Tada; Futoshi Yamanaka; Akihiro Higashimori; Kensuke Takagi; Hiroshi Ueno; Minoru Tabata; Kazuki Mizutani; Masanori Yamamoto; Kentaro Hayashida
Journal:  PLoS One       Date:  2019-12-26       Impact factor: 3.240

5.  Impact of bleeding complications after transcatheter mitral valve repair.

Authors:  Michael Paukovitsch; Niklas Schepperle; Alexander Pott; Dominik Buckert; Leonhard Moritz Schneider; Mirjam Keßler; Christine Reichart; Wolfgang Rottbauer; Sinisa Markovic
Journal:  Int J Cardiol Heart Vasc       Date:  2021-01-06

6.  Female gender and the clinical and periprocedural profile and clinical outcomes of transcatheter aortic valve implantation: experiences of a tertiary Polish centre.

Authors:  Krzysztof Wilczek; Piotr Chodór; Maciej Dyrbuś; Michał Hawranek; Łukasz Włoch; Łukasz Pyka; Tomasz Hrapkowicz; Michał Zembala; Zbigniew Kalarus; Mariusz Gąsior
Journal:  Postepy Kardiol Interwencyjnej       Date:  2020-12-29       Impact factor: 1.426

Review 7.  Towards Personalized Therapy of Aortic Stenosis.

Authors:  Piotr Mazur; Magdalena Kopytek; Michał Ząbczyk; Anetta Undas; Joanna Natorska
Journal:  J Pers Med       Date:  2021-12-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.